Results 281 to 290 of about 2,314,937 (397)

Applications of bioactive herbal extracts in dressing materials for skin wound repair: Ingredients, mechanisms and innovations

open access: yesInterdisciplinary Medicine, EarlyView.
Abstract The skin, as the body's largest organ, plays essential roles in protection, immune regulation, and homeostasis. Skin trauma, especially chronic wounds such as diabetic ulcers, poses significant clinical challenges. Traditional treatments, while often effective, can be costly and pose risks.
Boxiang Yang   +12 more
wiley   +1 more source

Herbal Medicine Use Among Transplant Recipients in Saudi Arabia: Prevalence and Risk Awareness. [PDF]

open access: yesAnn Transplant
Almalki BA   +19 more
europepmc   +1 more source

Chinese herbal medicine‐derived extracellular vesicle‐like particles: Therapeutic potential and future research approaches

open access: yesInterdisciplinary Medicine, EarlyView.
This article evaluates the therapeutic potential of extracellular vesicle‐like particles derived from Chinese herbal medicine (CHM‐EVLP) for a range of diseases. It underscores the significance of traditional Chinese medicine in the development of innovative formulations.
Ying‐qi Cao   +6 more
wiley   +1 more source

Advantages of regional development—A study on poverty alleviation in contiguous destitute areas

open access: yesInternational Studies of Economics, EarlyView.
Abstract The 2011–2020 period is the final stage of poverty alleviation in China, which emphasizes regional development. Using county‐level panel data from 2006 to 2015, we explore the impact of regional poverty alleviation policy on economic growth of contiguous destitute areas (CDAs) in China.
Du Hongyu
wiley   +1 more source

Effects of Hepatic or Renal Impairment on Pharmacokinetics of Fruquintinib

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Fruquintinib (FRUZAQLATM) is a highly selective tyrosine kinase inhibitor of all three vascular endothelial growth factor receptors (‐1, ‐2, and ‐3). Two Phase 1, open‐label, single‐dose studies investigated the impact of hepatic or renal impairment on the pharmacokinetics and tolerability of fruquintinib.
Martha Gonzalez   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy